BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6170832)

  • 21. Cell lineage and the differentiation of corneal epithelial cells.
    Beebe DC; Masters BR
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1815-25. PubMed ID: 8759349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis.
    Conrad TJ; Chandler DB; Corless JM; Klintworth GK
    Lab Invest; 1994 Mar; 70(3):426-34. PubMed ID: 7511717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
    Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Wound healing of the corneal posterior surface in animal experiments].
    Gloor B; Gloor ML; Merz-Hill M; Marshall J; Meszaros J; Daicker B
    Klin Monbl Augenheilkd; 1986 Mar; 188(3):225-30. PubMed ID: 3713094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
    Philipp W; Speicher L; Humpel C
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A morphological study of experimental corneal neovascularization].
    Ding Z; He Y; Wei H
    Zhonghua Yan Ke Za Zhi; 1995 Jan; 31(1):49-51. PubMed ID: 7781427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a new slice-culture method to study epithelial corneal pathophysiology in the paradigm of corneovascular interactions.
    Thanos S; Steuhl KP; Thanos R; Thiel HJ
    Ger J Ophthalmol; 1996 Nov; 5(6):466-78. PubMed ID: 9479538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of corneal epithelium turnover in vivo. Studies of lovastatin.
    Cenedella RJ; Fleschner CR
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1957-62. PubMed ID: 2210991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fas-Fas ligand system and other modulators of apoptosis in the cornea.
    Wilson SE; Li Q; Weng J; Barry-Lane PA; Jester JV; Liang Q; Wordinger RJ
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1582-92. PubMed ID: 8675401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA synthesis during the development of the chick cornea.
    Nuttall RP
    J Exp Zool; 1976 Nov; 198(2):193-208. PubMed ID: 978170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.
    Moore JE; McMullen TC; Campbell IL; Rohan R; Kaji Y; Afshari NA; Usui T; Archer DB; Adamis AP
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2905-15. PubMed ID: 12202509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of bFGF and TNF-alpha in the course of inflammatory angiogenesis in the mouse cornea.
    Sunderkötter C; Roth J; Sorg C
    Am J Pathol; 1990 Sep; 137(3):511-5. PubMed ID: 1698023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone.
    Zagon IS; Sassani JW; McLaughlin PJ
    Cornea; 2006 Aug; 25(7):821-9. PubMed ID: 17068460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
    Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
    Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
    Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
    Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas.
    McGowan SL; Edelhauser HF; Pfister RR; Whikehart DR
    Mol Vis; 2007 Oct; 13():1984-2000. PubMed ID: 17982423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.
    Yu H; Wu J; Li H; Wang Z; Chen X; Tian Y; Yi M; Ji X; Ma J; Huang Q
    Biochem Biophys Res Commun; 2007 Oct; 361(4):946-52. PubMed ID: 17692288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence suggesting the existence of stem cells for the human corneal endothelium.
    Whikehart DR; Parikh CH; Vaughn AV; Mishler K; Edelhauser HF
    Mol Vis; 2005 Sep; 11():816-24. PubMed ID: 16205623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limbal lymphangiogenesis after corneal injury: an autoradiographic study.
    Junghans BM; Collin HB
    Curr Eye Res; 1989 Jan; 8(1):91-100. PubMed ID: 2707040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.